Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1145520190050020101
Journal of Radiopharmaceuticals and Molecular Probes
2019 Volume.5 No. 2 p.101 ~ p.112
Comparative study of 2-nitroimidazole-fluorophore-conjugated derivatives with pimonidazole for imaging tumor hypoxia
Seelam Sudhakara Reddy

Hong Mi-Kyung
Lee Yun-Sang
Jeong Jae-Min
Abstract
Herein, 2-nitroimidazole-fluorophore conjugates were synthesized by linking 2-nitroimidazole and FITCor RITC via thiourea bonds. The prepared derivatives were stable for 2 h in Dulbecco¡¯s modified Eagle¡¯smedium (DMEM) at 37 ¡ÆC. The novel conjugates were studied for their in vitro uptake under hypoxic conditionsusing U87MG and CT-26 cell lines, showing significantly higher uptakes in hypoxic than normoxic cells.
Immunohistochemical analysis confirmed hypoxia in U87MG and CT-26 xenografted tumor tissues. Moreover,the prepared conjugates were evaluated by in vivo experiments after intravenous injection in U87MG andCT-26 xenografted mice. Hypoxia was confirmed by immunohistochemistry of the prepared derivatives withco-injected pimonidazole. Confocal microscopy of the prepared derivatives showed strong fluorescence inhypoxic tumor tissues correlated with the pimonidazole distribution. This suggested that the 2-nitroimidazolefluorophoreconjugates are promising optical imaging probes for tumor hypoxia and are promising substitutesfor pimonidazole immunohistochemistry, which requires a multi-step procedure of incubation involving antibody,second antibody, dye, hydrogen peroxide, and multiple washing steps.
KEYWORD
FITC, RITC, immunohistochemistry, hypoxia, 2-nitroimidazole-FITC, and 2-nitroimidazole-RITC
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)